Capricor signals readiness for deramiocel approval with $145M in cash and expanded commercial launch preparations Capricor signals readiness for deramiocel approval with $145M in cash and expanded commercial launch preparations Post ContentcaprRead More You might also be interested in reading Insider buying boosts Coty shares. May 14, 2025 In Mainstream ← Previous post Next post →